| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcff13f8573db698307f919e6385d5c4 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10 |
| filingDate |
2011-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c165b5f6c92dc4ac0e0bc317404c082f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_508e64e46503c27731dabe9a1d102da6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a900e72f4d984fdfd063f29934e2948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d0fac5157e7815247ab27c9973500d |
| publicationDate |
2012-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201201798-A |
| titleOfInvention |
Biomarkers for MDM2 inhibitors for use in treating disease |
| abstract |
Provided herein are methods for selecting and treating a subject with leukemia, wherein the subject is selected for treratment and is treated with an MDM2 inhibitor because said subject's cells contain an FLT3-ITD mutation. |
| priorityDate |
2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |